| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5832145 | International Immunopharmacology | 2015 | 6 Pages |
Abstract
Immunomodulatory therapy that combines ulinastatin and Tα1 significantly improves all-cause mortality, inflammatory mediators and duration of mechanical ventilation in subjects with sepsis.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Dong Han, Wenli Shang, Guizuo Wang, Li Sun, Yingying Zhang, Hongxia Wen, Lingbin Xu,